Identifying youth at high risk for sexually transmitted infections in community-based settings using a risk prediction tool: a validation study.
Adolescents
Risk prediction tool
Screening
Sexually transmitted infections
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
08 Dec 2021
08 Dec 2021
Historique:
received:
18
09
2021
accepted:
30
11
2021
entrez:
9
12
2021
pubmed:
10
12
2021
medline:
15
12
2021
Statut:
epublish
Résumé
BACKGROUND : Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are the most common bacterial sexually transmitted infections (STIs) worldwide. In the absence of affordable point-of-care STI tests, WHO recommends STI testing based on risk factors. This study aimed to develop a prediction tool with a sensitivity of > 90% and efficiency (defined as the percentage of individuals that are eligible for diagnostic testing) of < 60%. This study offered CT/NG testing as part of a cluster-randomised trial of community-based delivery of sexual and reproductive health services to youth aged 16-24 years in Zimbabwe. All individuals accepting STI testing completed an STI risk factor questionnaire. The outcome was positivity for either CT or NG. Backwards-stepwise logistic regression was performed with p ≥ 0.05 as criteria for exclusion. Coefficients of variables included in the final multivariable model were multiplied by 10 to generate weights for a STI risk prediction tool. A maximum likelihood Receiver Operating Characteristics (ROC) model was fitted, with the continuous variable score divided into 15 categories of equal size. Sensitivity, efficiency and number needed to screen were calculated for different cut-points. From 3 December 2019 to 5 February 2020, 1007 individuals opted for STI testing, of whom 1003 (99.6%) completed the questionnaire. CT/NG prevalence was 17.5% (95% CI 15.1, 19.8) (n = 175). CT/NG positivity was independently associated with being female, number of lifetime sexual partners, relationship status, HIV status, self-assessed STI risk and past or current pregnancy. The STI risk prediction score including those variables ranged from 2 to 46 with an area under the ROC curve of 0.72 (95% CI 0.68, 0.76). Two cut-points were chosen: (i) 23 for optimised sensitivity (75.9%) and specificity (59.3%) and (ii) 19 to maximise sensitivity (82.4%) while keeping efficiency at < 60% (59.4%). The high prevalence of STIs among youth, even in those with no or one reported risk factor, may preclude the use of risk prediction tools for selective STI testing. At a cut-point of 19 one in six young people with STIs would be missed.
Identifiants
pubmed: 34879820
doi: 10.1186/s12879-021-06937-4
pii: 10.1186/s12879-021-06937-4
pmc: PMC8653586
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1234Subventions
Organisme : Wellcome Trust
ID : 206316/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T040327/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206316_Z_17_Z
Pays : United Kingdom
Informations de copyright
© 2021. The Author(s).
Références
Sex Transm Dis. 2014 May;41(5):321-30
pubmed: 24722388
Trop Med Int Health. 2018 May;23(5):541-548
pubmed: 29505113
Sex Transm Infect. 2016 Feb;92(1):12-8
pubmed: 25933609
BMC Infect Dis. 2018 Nov 26;18(1):596
pubmed: 30477441
Br J Gen Pract. 2006 Aug;56(529):587-93
pubmed: 16882376
Sex Transm Infect. 2017 Dec;93(8):599-606
pubmed: 28325771
BMC Med Res Methodol. 2013 Jan 31;13:11
pubmed: 23368888
Sex Transm Dis. 2011 Nov;38(11):1004-11
pubmed: 21992975
Sex Health. 2005;2(3):185-92
pubmed: 16335546
Int J STD AIDS. 2018 Mar;29(4):324-333
pubmed: 28799824
Lancet Child Adolesc Health. 2021 Feb;5(2):122-132
pubmed: 33417838
Bull World Health Organ. 2019 Aug 1;97(8):548-562P
pubmed: 31384073
Trop Med Int Health. 2011 Mar;16(3):349-55
pubmed: 21176006
BMC Infect Dis. 2007 Apr 16;7:27
pubmed: 17437632
Lancet Infect Dis. 2019 Jun;19(6):658-669
pubmed: 31031172
Sex Transm Infect. 1998 Jun;74 Suppl 1:S139-46
pubmed: 10023365
BMC Public Health. 2021 Apr 16;21(1):738
pubmed: 33863295
Sex Transm Dis. 2011 Mar;38(3):167-71
pubmed: 20852454
Int J STD AIDS. 2018 Jul;29(8):806-824
pubmed: 29486628
PLoS One. 2016 Jan 25;11(1):e0147828
pubmed: 26808547
PLoS Med. 2018 Feb 27;15(2):e1002511
pubmed: 29485986
PLoS One. 2018 Apr 24;13(4):e0196209
pubmed: 29689080
Sex Transm Infect. 2019 May;95(3):201-211
pubmed: 30242143
Sex Transm Infect. 2019 Feb;95(1):60-66
pubmed: 30228109
Sex Transm Infect. 2017 Dec;93(S4):S31-S35
pubmed: 28684611
J Clin Microbiol. 2018 Sep 25;56(10):
pubmed: 30021825
PLoS One. 2016 Dec 22;11(12):e0168580
pubmed: 28006003
Clin Microbiol Infect. 2010 Aug;16(8):1062-9
pubmed: 20670288
Pediatr Infect Dis J. 2016 Aug;35(8):894-900
pubmed: 27164464
Sex Transm Infect. 2011 Mar;87(2):165-73
pubmed: 20943824
J Int AIDS Soc. 2020 Jun;23 Suppl 2:e25517
pubmed: 32589346
JAMA Netw Open. 2020 May 1;3(5):e204819
pubmed: 32407506
BMC Infect Dis. 2018 Oct 3;18(1):499
pubmed: 30285705
Int J STD AIDS. 2018 May;29(6):531-539
pubmed: 29198180
BMC Pregnancy Childbirth. 2018 Jun 18;18(1):240
pubmed: 29914397
Sex Transm Dis. 2004 May;31(5):283-9
pubmed: 15107630
Sex Transm Infect. 1999 Feb;75(1):3-17
pubmed: 10448335
Int Perspect Sex Reprod Health. 2013 Mar;39(1):14-21
pubmed: 23584464
Sex Transm Dis. 2014 Sep;41(9):564-9
pubmed: 25118973
Matern Child Health J. 2018 Jun;22(6):812-821
pubmed: 29417367
BMC Infect Dis. 2021 Apr 28;21(1):392
pubmed: 33910514